Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease

Abstract

Developing biomarkers that distinguish individuals with Alzheimer's disease (AD) from those with normal cognition remains a crucial goal for improving the health of older adults. We investigated adding brain spatial information to temporal event‐related potentials (ERPs) to increase AD identification accuracy over temporal ERPs alone.

Document Details

• Document Type: Pub Defense Publication
• Publication Date: Jan 01, 2018
• Source ID: 10.1016/j.dadm.2018.08.002

Entities

People

• Anton P. Porsteinsson
• Inga M. Antonsdottir
• Lily Kamalyan
• Margaret N. Gardner
• Mark Mapstone
• Rafael Klorman
• Robert M. Chapman

Organizations

• AstraZeneca
• Biogen
• Eisai
• Merck & Co.
• National Eye Institute
• National Institute of Mental Health
• National Institute on Aging
• National Institutes of Health
• Taisho Pharmaceutical Co.
• United States Department of Defense
• University of California, Irvine
• University of Rochester

Tags

Fields of Study

• Psychology

Readers

• Computational Linguistics
• Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.